Tell me dosing protocol of cyclophosphamide mmf and mps
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have extensive, authoritative data from multiple textbooks. Let me compile the comprehensive answer.
Dosing Protocols: Cyclophosphamide (CYC), Mycophenolate Mofetil (MMF), and Methylprednisolone (MPS)
These three agents are the backbone of immunosuppressive therapy, most commonly used for lupus nephritis (LN), vasculitis, and other autoimmune conditions. Their protocols are divided into induction and maintenance phases.
1. Cyclophosphamide (CYC)
A. NIH High-Dose IV Pulse Protocol (Standard)
| Step | Detail |
|---|---|
| Prerequisite | Calculate GFR (Cockcroft-Gault or MDRD) and BSA (m²) = √[Height(cm) × Weight(kg)/3600] |
| Initial dose | 0.75 g/m² IV; reduce to 0.5 g/m² if GFR < 1/3 of expected normal |
| Administration | CYC in 150 mL normal saline IV over 30-60 min |
| Dose escalation | Titrate up to maximum 1 g/m² per pulse based on WBC nadir (see monitoring) |
| Schedule | Monthly (every 3 weeks in extremely aggressive disease) x 6-7 pulses total |
| Maintenance | Quarterly doses for 1 year after remission is achieved |
B. Euro-Lupus Low-Dose IV Protocol (Preferred for most patients)
| Detail | Dose |
|---|---|
| Dose | Fixed 500 mg IV every 2 weeks x 6 doses (total 3 g) |
| Indication | Proliferative LN (classes III/IV) without severe renal impairment (sCr < 2.5 mg/dL), without extensive crescents/necrosis |
| Efficacy | Similar remission rates and 5-10 year kidney outcomes vs. NIH high-dose, with fewer infections and less toxicity |
C. Oral CYC
- 2 mg/kg/day orally (used in some vasculitis protocols)
Monitoring & Safety (IV CYC)
- WBC nadir check: Days 10 and 14 after each pulse (hold prednisone before blood draw to avoid false leukocytosis)
- Dose adjustment: Keep WBC nadir >1500/mm³; if nadir <1500/mm³, reduce next dose by 25%
- Bladder protection (hemorrhagic cystitis prevention):
- IV hydration: 5% dextrose + 0.45% saline, 2 L at 250 mL/hr
- Encourage high oral fluid intake for 24 hours
- Mesna: 20% of CYC dose IV at 0, 2, 4, and 6 hours after CYC (especially in outpatient settings or where diuresis is hard to maintain)
- If diuresis is difficult (e.g., nephrotic syndrome): insert 3-way catheter with continuous bladder flushing
- Antiemetics: Ondansetron 8 mg TID x 1-2 days, or granisetron 1 mg with CYC dose (repeat in 12 hours)
- Gonadal protection: Consider leuprolide 3.75 mg SC 2 weeks before each CYC dose in high-risk females
2. Mycophenolate Mofetil (MMF)
Dosing by Indication
| Indication | Induction Dose | Maintenance Dose |
|---|---|---|
| Lupus nephritis (LN) - induction | 2-3 g/day orally (in 2 divided doses) | 1-2 g/day |
| LN - maintenance | - | 1-2 g/day (often as monotherapy with low-dose steroid) |
| Myositis/ILD | 1 g bid, up to 1.5 g bid | 1-1.5 g bid |
| Pediatric cSLE | Up to 600 mg/m²/dose BID (max 1500 mg BID) | same |
| Dermatologic (pemphigus) | 30-40 mg/kg/day (max 3 g/day) BID | 2-3 g/day |
Key Points
- MMF vs. NIH-CYC: Non-inferior to 6 monthly IV CYC pulses + steroids for induction of proliferative LN, with a better safety profile
- MMF is taken orally twice daily (BID)
- Mycophenolate sodium (enteric-coated) is the alternative: dose conversion is MMF 250 mg = mycophenolate sodium 180 mg
- Avoid in pregnancy (teratogenic - Category D); switch to azathioprine
3. Methylprednisolone Pulse (MPS)
Induction Pulse Regimens
| Protocol | MPS Dose | Schedule |
|---|---|---|
| Standard induction (LN) | 500-1000 mg/pulse IV | 1-3 consecutive daily pulses |
| KDIGO/current guideline range | 250-2500 mg total cumulative | Over 1-3 days (severity-guided) |
| Euro-Lupus (ELNT) | Three pulses of 750 mg | Then oral prednisolone 0.5 mg/kg/day |
| RITUXILUP protocol | Two pulses of 500 mg | Then MMF maintenance (steroid-sparing approach) |
| Life-threatening disease (cardiac tamponade, severe hepatic involvement, DIC) | 1000 mg/day x 3 | Daily x 3 |
| Transplant rejection | 250-500 mg | 3-5 day course |
Oral Steroid Follow-up After IV Pulse
- Start oral prednisone/prednisolone at 0.3-1 mg/kg/day
- Taper to ≤7.5 mg/day by 3-6 months
- Trend is toward steroid minimization - modern protocols use lower pulse doses (500 mg) and faster tapers
Summary Comparison Table
| Drug | Route | Induction | Maintenance | Key Concern |
|---|---|---|---|---|
| CYC (NIH) | IV | 0.75 g/m² monthly x 6-7 | Quarterly x 1 yr | Bladder toxicity, gonadal failure |
| CYC (Euro-Lupus) | IV | 500 mg q2wk x 6 | Azathioprine or MMF | Less toxic, preferred |
| CYC (oral) | PO | 2 mg/kg/day | - | Cumulative toxicity higher |
| MMF | PO | 2-3 g/day | 1-2 g/day | Teratogenic, GI side effects |
| MPS pulse | IV | 500-1000 mg/day x 1-3 | Oral prednisone taper | Hyperglycemia, infection |
Sources:
- Comprehensive Clinical Nephrology, 7th Edition (Sections: Treatment of LN, Glucocorticoids, Immunosuppressive Agents)
- Firestein & Kelley's Textbook of Rheumatology (Table 82.3: NIH Protocol for Pulse IV CYC)
- Goldman-Cecil Medicine (Management of Lupus Nephritis)
- NKF Primer on Kidney Diseases, 8e (Induction Therapy - LN)
- Harrison's Principles of Internal Medicine, 22e (Immunotherapy dosing)
This is a shared conversation. Sign in to Orris to start your own chat.